Developing non-traditional antibiotics promises novel strategies to combat multidrug-resistant organisms but would they work? Are they feasible to develop? Topics discussed:   • The notion of non-traditional antibiotics as potential therapeutics against MDR organisms   • Increasing our understanding on the clinical efficacy of non-traditional antibiotics   • Regulatory pathways for approval of such compounds  Guest: Dr. John Rex, Chief Medical Officer, F2G Ltd. | Editor-in-Chief, AMR.solutions Visit https://aac.asm.org to browse issues and/or submit a manuscript.

Developing non-traditional antibiotics promises novel strategies to combat multidrug-resistant organisms but would they work? Are they feasible to develop? Topics discussed: • The notion of non-traditional antibiotics as potential therapeutics against MDR organisms • Increasing our understanding on the clinical efficacy of non-traditional antibiotics • Regulatory pathways for approval of such compounds Guest: Dr. John Rex, Chief Medical Officer, F2G Ltd. | Editor-in-Chief, AMR.solutions Visit https://aac.asm.org to browse issues and/or submit a manuscript.

Developing Non-Traditional Antibiotics (AAC ed.)

Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more.

The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.

Science

Life Sciences

Natural Sciences

Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more. The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.

Share Developing Non-Traditional Antibiotics (AAC ed.)

Sign up to save your podcasts

Developing Non-Traditional Antibiotics (AAC ed.)

Developing Non-Traditional Antibiotics (AAC ed.)

More shows like Editors in Conversation

MicrobeWorld Video

Meet the Microbiologist

This Week in Virology

Microbios

This Week in Parasitism

BacterioFiles

MicrobeWorld Video HD

MicrobeWorld Video (audio only)

NEJM This Week

This Week in Microbiology

JAMA Clinical Reviews

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

Immune

Annals On Call Podcast

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Breakpoints

Febrile

Let's Talk Micro

Infectious Disease Puscast

Communicable